Fig. 1.
Characteristics of postoperative complications_
| Characteristics | Number of cases n = 47 |
|---|---|
| Infection | |
| Early (≤ 30 days) | 6 (12.8) |
| Late (> 30 days) | |
| 31-90 days | 11 (23.4) |
| 91-365 days | 17 (36.2) |
| > 365 days | 5 (10.6) |
| – Local recurrence of breast cancer | 2 (4.3) |
| – Local recurrence of breast cancer in the chest wall | 2 (4.3) |
| – Postoperative pain | 1 (2.1) |
| – Leakage of prosthesis/expander prosthesis | 2 (4.3) |
| – No data | 1 (2.1) |
Clinical and histopathological characteristics of patients with implant loss, and the type of reconstruction_
| Characteristics | Number of cases n = 47 |
|---|---|
| Type of carcinoma | |
| Ductal carcinoma | 36 (76.6) |
| Lobular carcinoma | 2 (4.3) |
| Other forms of invasive cancer | 3 (6.4) |
| DCIS | 4 (8.5) |
| No data | 2 (4.3) |
| Clinical stage (cTNM) | |
| IA | 14 (29.8) |
| IIA | 17 (36.2) |
| IIB | 5 (10.6) |
| IIIA | 2 (4.3) |
| IIIB | 1 (2.1) |
| No data | 8 (17.0) |
| Diabetes | |
| Yes | 3 (6.4) |
| No | 44 (93.6) |
| Nicotinism | |
| Yes | 2 (4.3) |
| No | 36 (76.6) |
| No data | 9 (19.1) |
| BMI [kg/m2] | |
| < 25 | 21 (44.7) |
| ≥ 25 | 26 (55.3) |
| MSSA carrier | |
| Yes | 8 (17.0) |
| No | 26 (55.3) |
| No data | 13 (27.7) |
| Type of reconstruction | |
| Immediate | 20 (42.6) |
| Deferred | 27 (57.4) |
| Type of implant | |
| Expander | 23 (48.9) |
| Expander prosthesis | 8 (17.0) |
| Prosthesis | 5 (10.6) |
| Expander prosthesis/prosthesis (2nd stage of reconstruction - replacement of implant after earlier implantation of expander) | 11 (23.4) |
Characteristics of pre- and post-implantation treatment of cancer patients_
| Characteristic | Number of cases n = 47 |
|---|---|
| Pre-implantation treatment: | |
| – RTH | 1 (2.1) |
| – CHTH | 13 (27.7) |
| – RTH+CHTH | 13 (27.7) |
| – No treatment | 19 (40.4) |
| – No data | 1 (2.1) |
| Post-implantation treatment: | |
| – RTH | 1 (2.1) |
| – CHTH | 4(8.5) |
| – RTH+CHTH | 1 (2.1) |
| – No treatment | 40 (85.1) |
| – No data | 1 (2.1) |